Skip to content

IQVIA IQV Price / book

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
UnitedHealth Group logo
UnitedHealth GroupUNH
2.4×-2.4×
Labcorp Holdings logo
Labcorp HoldingsLH
2.5×+0.2×
Cognizant logo
CognizantCTSH
1.9×-0.6×
Oracle logo
OracleORCL
10.9×-16.9×
Veeva Systems logo
Veeva SystemsVEEV
3.5×-2.5×

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$28B-7.9%
Enterprise value$42.12B-2.5%
P/E20.2×-2.6×
P/S1.7×-0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Calculated from IQVIA’s reported figures.

Based on the most recent quarter.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's price / book?
IQVIA (IQV) reported price / book of 4.6× in Q1 2026.
How has IQVIA's price / book changed year-over-year?
IQVIA's price / book decreased by 11.5% year-over-year, from 5.2× to 4.6×.
What is the long-term trend for IQVIA's price / book?
Over 5 years (2020 to 2025), IQVIA's price / book has grown at a 0.6% compound annual growth rate (CAGR), from 5.7× to 5.9×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.